/24-7PressRelease/ - MONROVIA, CA, June 20, 2008 - Michele Pontinen, Senior Manager of Life Sciences at Capgemini LLC will be speaking at GTCbio's Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA. Ms. Pontinen will give a presentation entitled "Forget About the Boulders - I'm Interested in Mining for the Diamonds!" Data Mining (And Other Capabilities) Made Possible by Clinical IT - a Real Life Industrialized Model."
Data mining has always been important to Capgemini's industry. Having the ability to mine across pre-clinical, Phase I-III research trials and marketing studies as well as other external data has always been the goal. To date, data and systems 'interoperability' has been one of the major challenges to this effort. In Capgemini's current state, they are able, albeit infrequently, to cull-out major safety and efficacy information (the boulders). Ms. Pontinen and her colleagues are hampered, however, in mining for those diamonds that can give them more accurate and focused insight into product extensions, safety information and treatment. This presentation will discuss a current solution they have 'industrialized' for a client. The solution includes a repository for mining across data in an interoperable formatting, using industry standards available to them today, the toolset used to migrate closed studies (studies reported to authorities) and convert in-live (on-going trials) to a new EDC platform with pass through to the repository. Ms. Pontinen will present the challenges and pitfalls to enabling this functionality and discuss how Clinical IT Operations can make this model successful and drive the right solution for the business owners and for operations. Ms. Pontinen will define what 'interoperable' means for systems and data, provide insight into the challenges of driving this solution, explain how Capgemini 'industrialized' the process, and present other benefits in addition to data mining capability.
The Global Clinical Trial Operations conference brings together leaders, directors, vice presidents, heads, managers, supervisors, and CROs from all over the world to collaborate and discuss the latest developments in clinical trial operations and logistics and covers clinical trials in emerging markets, first-in-man clinical trials, pediatric clinical trials, material storage, distribution, site selection, patient recruitment and retention, technology in clinical trials and case studies of running global clinical trials.
For more information including a detailed agenda, exhibitor opportunities and registration information visit http://gtcbio.com/conferenceDetails.aspx?id=127.
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com# # #
Read more Press Releases from Rania Hafez:- Joost Oppenheim, M.D., Laboratory Chief - NCI, to give Keynote Presentation at GTCbio's 8th Cytokines & Inflammation Conference on January 28-29, 2010 in San Diego, CA
- Vaccines: All Things Considered Conference to be held by GTCbio on November 9-10, 2009 in Washington, DC
- Translational Medicine Track of the GTCbio 5th Annual Modern Drug Discovery & Development Conference to be held on October 14-16, 2009 in San Diego, CA
- Amy Scott-Billman, VP at GlaxoSmithKline to do Keynote at Modern Drug Discovery & Development Summit
- Biological Therapeutics to be an Important Focus at the 5th Modern Drug Discovery & Development Summit held by GTCbio on October 14-16, 2009 in San Diego, CA.
- GTCbio Announces 4th Annual Assay Development and Screening Conference taking place June 8-9, 2009.
- Dr. Joseph Bolen, CSO of Millennium to give Keynote Presentation at GTCbio's 4th Annual Protein Kinases in Drug Discovery Conference taking place on May 4-5, 2009 in Boston, MA
- GTCbio Announces its Inaugural Ocular Diseases & Drug Discovery conference, taking place on April 20-21, 2009 in Philadelphia, Pennsylvania.
- Pete Adamson, Head of Research for Ophthiris at GlaxoSmithKline to give Keynote Presentation at GTCbio's Inaugural Ocular Diseases & Drug Discovery conference, taking place on April 20-21, 2009 in Philadelphia, PA.
- Alison Goss Eng of US Dept. of Energy to Present at GTCbio's Inaugural Biofuels: Science and Innovation for Sustainable Development Conference on June 29-30, 2009 in San Francisco, CA
